These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 8610137

  • 1. Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.
    Woffendin C, Ranga U, Yang Z, Xu L, Nabel GJ.
    Proc Natl Acad Sci U S A; 1996 Apr 02; 93(7):2889-94. PubMed ID: 8610137
    [Abstract] [Full Text] [Related]

  • 2. Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells.
    Woffendin C, Yang ZY, Udaykumar, Xu L, Yang NS, Sheehy MJ, Nabel GJ.
    Proc Natl Acad Sci U S A; 1994 Nov 22; 91(24):11581-5. PubMed ID: 7972106
    [Abstract] [Full Text] [Related]

  • 3. Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals.
    Ranga U, Woffendin C, Verma S, Xu L, June CH, Bishop DK, Nabel GJ.
    Proc Natl Acad Sci U S A; 1998 Feb 03; 95(3):1201-6. PubMed ID: 9448309
    [Abstract] [Full Text] [Related]

  • 4. Genetic modification of human peripheral blood lymphocytes with a transdominant negative form of Rev: safety and toxicity.
    Fox BA, Woffendin C, Yang ZY, San H, Ranga U, Gordon D, Osterholzer J, Nabel GJ.
    Hum Gene Ther; 1995 Aug 03; 6(8):997-1004. PubMed ID: 7578421
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
    Junker U, Böhnlein E, Veres G.
    Gene Ther; 1995 Nov 03; 2(9):639-46. PubMed ID: 8548553
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector.
    Inouye RT, Du B, Boldt-Houle D, Ferrante A, Park IW, Hammer SM, Duan L, Groopman JE, Pomerantz RJ, Terwilliger EF.
    J Virol; 1997 May 03; 71(5):4071-8. PubMed ID: 9094685
    [Abstract] [Full Text] [Related]

  • 19. Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragments.
    Duan L, Zhu M, Bagasra O, Pomerantz RJ.
    Hum Gene Ther; 1995 Dec 03; 6(12):1561-73. PubMed ID: 8664381
    [Abstract] [Full Text] [Related]

  • 20. The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.
    Liem SE, Ramezani A, Li X, Joshi S.
    Hum Gene Ther; 1993 Oct 03; 4(5):625-34. PubMed ID: 8280800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.